567 participants
Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-10-19
- Start Date:
- 2017-03-01
- Completion:
- 2019-09-09
Conditions
- Pancreatic Cancer
Interventions
- BIOLOGICAL
- DRUG